Enterome

Delivering the promise of cancer immunotherapy

Paris, France · Founded 2011 · $19.0M raised

Headquarters
Paris
Founded
2011
Total Funding
$19.0M
Last Round
$19.0M Series EJun 2025
Rounds
6

About

Enterome is a clinical-stage company developing off-the-shelf, transformational cancer treatments targeting a wide range of tumor types, including glioblastoma, adrenal tumors, non-Hodgkin lymphoma, and colorectal cancer. Phase 2 trials of its programs, EO2463, EO4010, and EO2401, have shown promising efficacy with good safety profiles in over 240 patients. The company's OncoMimics approach generates a powerful, long-lasting immune response from a patient's own effector memory T cells, effectively overcoming immune tolerance to self-antigens.

Summary

Enterome is a Biotech company based in Paris, France, founded in 2011. It has raised $19.0M in total across 6 rounds, most recently a $19.0M Series E round in Jun 2025. Investors include Seventure Partners, Lundbeckfond Ventures and SymBiosis II.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries EJun 2025
$19.0M

Sign up to see all 6 rounds

Series A through Series E — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Enterome on Indexed.vc
<a href="https://indexed.vc/companies/enterome"><img src="https://indexed.vc/api/badge/company/enterome" alt="Enterome on Indexed.vc" width="260" height="76" /></a>